Reckitt Benckiser Healthcare (Scandinavia) A/S
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- GALIEVE MINT oral suspension 500 mg/10 ml+267 mg/10 ml+160 mg/10 ml
- GALIEVE oral suspension 500 mg/10 ml+213 mg/10 ml+325 mg/10 ml
- GALIEVE PEPPERMINT chewable tablet 250 mg+133.5 mg+80 mg
- R02 - Preparados para la garganta
- FLURBIPROFEN RECKITT BENCKISER lozenge 8.75 mg
- STEFLAM compressed lozenge 8.75 mg
- STREFEN HUNAJA-SITRUUNA oromucosal spray 16.2 mg/ml
- STREFEN KIRSIKKA MINTTU oromucosal spray 16.2 mg/ml
- STREFEN ORANGE lozenge 8.75 mg
- STREPSILS APPELSIINI lozenge 1.2 mg+0.6 mg
- STREPSILS HUNAJA AND SITRUUNA lozenge 1.2 mg+0.6 mg
- STREPSILS INKIVAARI lozenge 1.2 mg+0.6 mg
- STREPSILS MANSIKKA lozenge 1.2 mg+0.6 mg
- STREPSILS MENTHOL lozenge 1.2 mg+0.6 mg
- STREPSILS MINT lozenge 1.2 mg+0.6 mg
- STREPSILS SITRUS lozenge 1.2 mg+0.6 mg